People with ankylosing spondylitis (AS) are more likely to develop osteoporosis than the general population, and also seem to…
Articles by Patricia Inacio PhD
The diagnosis of rare diseases such as akylosing spondylitis (AS) is complex and often delayed. A partnership between U.S. researchers…
Women with axial spondyloarthritis (axSpA) are diagnosed significantly later compared to men, according to a new study. The presence of…
People with ankylosing spondylitis (AS)-related kyphosis — a “humpback” appearance — showed good post-surgery outcomes with a technique called satellite…
A new and citrate-free formulation of Taltz (ixekizumab) is being made available to treat adults with active ankylosing spondylitis (AS), and…
The first healthy volunteer in the U.S. has been dosed in a Phase 1 clinical trial evaluating IMG-004, an oral…
Health Canada has approved Rinvoq (upadacitinib) to treat active ankylosing spondylitis (AS) in adults who fail to respond to a biologic disease-modifying…
Obesity is a risk factor for worse overall health in people with ankylosing spondylitis (AS), and is associated…
Cosentyx (secukinumab) has been approved in the U.S. to treat people with active non-radiographic axial spondyloarthritis (nr-axSpA), its…
After its approval last year, Cimzia (certolizumab pegol) may now be the most prescribed therapy in the U.S. for…